DK1219301T3 - Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner - Google Patents

Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner

Info

Publication number: DK1219301T3
Authority: DK; Denmark
Prior art keywords: hybrid polypeptides; allergenic proteins; vaccines containing; polypeptides consisting; containing hybrid
Prior art date: 2000-12-28

Application number

DK01130292T

Other languages

English (en)

Inventor

Birgit Linhart

Dietrich Kraft

Rudolf Valenta

Original Assignee

Biomay Prod & Handel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-28

Filing date

2001-12-20

Publication date

2007-10-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170854&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1219301(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-20 Application filed by Biomay Prod & Handel filed Critical Biomay Prod & Handel

2007-10-22 Application granted granted Critical

2007-10-22 Publication of DK1219301T3 publication Critical patent/DK1219301T3/da

Links

230000002009 allergenic effect Effects 0.000 title abstract 3
229920001184 polypeptide Polymers 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
229960005486 vaccine Drugs 0.000 title abstract 2
239000012634 fragment Substances 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
102000040430 polynucleotide Human genes 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Botany (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

DK01130292T 2000-12-28 2001-12-20 Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner DK1219301T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP00128660A EP1221317A1 (en)	2000-12-28	2000-12-28	Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins

Publications (1)

Publication Number	Publication Date
DK1219301T3 true DK1219301T3 (da)	2007-10-22

Family

ID=8170854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01130292T DK1219301T3 (da)	2000-12-28	2001-12-20	Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner

Country Status (8)

Country	Link
US (2)	US7862828B2 (da)
EP (2)	EP1221317A1 (da)
AT (1)	ATE367826T1 (da)
DE (1)	DE60129528T2 (da)
DK (1)	DK1219301T3 (da)
ES (1)	ES2287067T3 (da)
HK (1)	HK1046648B (da)
PT (1)	PT1219301E (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60301944T2 (de)	2003-01-21	2006-06-01	Biomay Produktions- Und Handels-Aktiengesellschaft	Verfahren zur Vorbereitung von hypoallergenen Mosaikproteinen#
US8709435B2 (en)	2003-01-21	2014-04-29	Biomay Ag	Hypallergenic mosaic antigens and methods of making same
ITRM20030247A1 (it) *	2003-05-20	2004-11-21	Bonura Angela	Varianti ipoallergeniche degli allergeni maggiori
CN1886156A (zh) *	2003-09-30	2006-12-27	特莱索恩儿童健康研究院	免疫治疗方法
DE10351471A1 (de) *	2003-11-04	2005-06-09	Ursula Prof. Dr. Wiedermann-Schmidt	Polyvalente Allergievakzine
CN101141979B (zh) *	2005-03-18	2013-05-08	赛托斯生物技术公司	猫变应原融合蛋白及其用途
US20070065468A1 (en) *	2005-08-29	2007-03-22	National University Of Singapore	Chimeric allergens for immunotherapy
ES2307381B1 (es)	2006-04-12	2009-10-23	Bial Industrial Farmaceutica S.A.	Proteinas quimericas hipoalergenicas pertenecientes a la familia de transportadoras de lipidos de parietaria judaica utiles para el tratami ento de alergias.
AT503690A1 (de) *	2006-06-09	2007-12-15	Biomay Ag	Hypoallergene moleküle
MX2010010353A (es)	2008-03-25	2010-10-05	Bial Ind Farmaceutica S A	Proteinas hibridas hipoalergenicas de los alergenos mayoritarios de acaros pertenecientes a los grupos 1 y 2 utiles para su utilizacion en el tratamiento de alergias.
EP2295076A1 (en) *	2009-09-10	2011-03-16	Biomay Ag	Hypoallergenic hybrid polypeptides for the treatment of allergy
ITMI20112301A1 (it) *	2011-12-19	2013-06-20	Lofarma Spa	Varianti ipoallergeniche dell'allergene maggiore phl p 5 di phleum pratense
ES2601220T3 (es)	2012-09-20	2017-02-14	Universidad De Cartagena	Proteínas de fusión con representación de diferentes alérgenos: propuesta de vacuna para alergia a los ácaros

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5116612A (en) *	1987-06-23	1992-05-26	Allergy Immuno Technologies, Inc.	Immunotherapy agents for treatment of IgE mediated allergies
JP2596466B2 (ja) *	1990-03-03	1997-04-02	アサヒビール株式会社	ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法
US5736362A (en) *	1990-10-26	1998-04-07	The University Of Melbourne	Ryegrass pollen allergen
PT100978B (pt)	1991-10-16	1999-10-29	Immulogic Pharma Corp	Peptidos recombitope, sequencias de acidos nucleicos que os codificam, composicoes terapeuticas que os contem, processo para a sua concepcao e sue uso.
US5968526A (en) *	1994-04-14	1999-10-19	Immulogic Pharamaceutical Corporation	T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
SE9402089D0 (sv) *	1994-06-14	1994-06-14	Rudolf Valenta	Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
GB9516293D0 (en)	1995-08-09	1995-10-11	Immunova Ltee	Novel peptides and their use as vaccines
GB9516760D0 (en) *	1995-08-16	1995-10-18	Sandoz Ltd	Organic compounds
US5804201A (en) *	1996-03-11	1998-09-08	The Rockefeller University	Immunomodulatory peptides of vespid antigen 5

2000
- 2000-12-28 EP EP00128660A patent/EP1221317A1/en not_active Withdrawn
2001
- 2001-12-20 DE DE60129528T patent/DE60129528T2/de not_active Expired - Lifetime
- 2001-12-20 EP EP01130292A patent/EP1219301B1/en not_active Expired - Lifetime
- 2001-12-20 AT AT01130292T patent/ATE367826T1/de not_active IP Right Cessation
- 2001-12-20 DK DK01130292T patent/DK1219301T3/da active
- 2001-12-20 ES ES01130292T patent/ES2287067T3/es not_active Expired - Lifetime
- 2001-12-20 PT PT01130292T patent/PT1219301E/pt unknown
- 2001-12-27 US US10/026,914 patent/US7862828B2/en not_active Expired - Fee Related
2002
- 2002-11-19 HK HK02108362.1A patent/HK1046648B/zh not_active IP Right Cessation
2010
- 2010-11-26 US US12/954,821 patent/US20110150920A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60129528D1 (de)	2007-09-06
ATE367826T1 (de)	2007-08-15
HK1046648A1 (en)	2003-01-24
EP1219301A1 (en)	2002-07-03
EP1219301B1 (en)	2007-07-25
DE60129528T2 (de)	2008-04-10
US20020173625A1 (en)	2002-11-21
PT1219301E (pt)	2007-09-04
EP1221317A1 (en)	2002-07-10
US7862828B2 (en)	2011-01-04
US20110150920A1 (en)	2011-06-23
HK1046648B (zh)	2007-10-26
ES2287067T3 (es)	2007-12-16

Publication	Publication Date	Title
TR200100056T2 (tr)	2001-11-21	Nörotrofik faktörler
ATE405647T1 (de)	2008-09-15	Rekombinantes gelatin in impstoffen
ATE500323T1 (de)	2011-03-15	Subtilisin-variante
DK1219301T3 (da)	2007-10-22	Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
CY1113421T1 (el)	2016-06-22	Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
EA199900355A1 (ru)	2000-08-28	Теломераза обратная тринскриптаза
DE50112802D1 (de)	2007-09-13	Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
PT1090033E (pt)	2005-05-31	Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
DE60030859D1 (de)	2006-11-02	Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
CY1117746T1 (el)	2017-05-17	Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
BR0012919A (pt)	2002-04-23	Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
AR035077A1 (es)	2004-04-14	Polipeptidos de neublastina variante, proteinas de fusion, acidos nucleicos, vectores, celulas hospedadoras, metodos para producir dichos polipeptidos, dimeros, conjugados, composiciones farmaceuticas y uso de dichos polipeptidos en la preparacion de medicamentos
NO20073914L (no)	2004-03-10	Biologisk aktive peptider
EP1613345A4 (en)	2007-01-10	COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
DE60118359D1 (de)	2006-05-18	Humanische pellino-polypeptide
EA200100395A1 (ru)	2001-10-22	Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
SE9602822D0 (sv)	1996-07-19	New receptor
DK1219299T4 (da)	2011-02-14	Allergivacciner og fremstilling deraf
DK0540560T3 (da)	1995-12-27	Ancrod-lignende proteiner, fremstilling og anvendelse deraf
WO2001055209A3 (en)	2001-12-13	Novel human septin and uses thereof
BR0016740A (pt)	2002-09-03	Antìgenos de esporozoìto de cryptosporidium
SE9901548D0 (sv)	1999-04-29	Helicobacter pylori antigens
AR025198A1 (es)	2002-11-13	Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su uso
WO2002079390A9 (en)	2013-10-24	$i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof
FI20011705A0 (fi)	2001-08-24	Luun morfogeneettisiä proteiineja